Details

NameSymbolSector
TORRENT PHARMACEUTICALS LTD.TORNTPHARMPharmaceuticals
Open
4900
High
4983.5
Low
4887
Close
4960
Volume
258478
Exchange
nse
Time
08-Sep-2026

Outlook

Score:

2

Rating:

RISKY

Candlestick Pattern

CandlepatternofTorrentPharmaceuticalsis
None
EstimatedStoplossofTorrentPharmaceuticalsis
4887
TorrentPharmaceuticalshasa
Bullishℹ
pattern.
Formationof
None
candlepatternindicatesthetrenddirectionofTorrentPharmaceuticalsis
Unpredictableℹ
.

Trend

TorrentPharmaceuticalsisin
Sideways trendℹ
.
PriceofTorrentPharmaceuticalsis
Upℹ
by

1.23

%.
Target
Buy@

4300.82

Sell@

5267.5

Current@

4960

Volume

ThetradevolumesofTorrentPharmaceuticalshavebecome
Deficientℹ
ThoughthevolumetrendforTorrentPharmaceuticalsappears
Bullishℹ
theparticipantsseemtobe
Weak Buyersℹ
ThetradevolumeofTorrentPharmaceuticalsis

Down

by

58.68

%

Valuation

ThecurrentmarketpriceofTorrentPharmaceuticalsis
Overvaluedℹ

Financials

Balance
Withtotalliablitiesandshareholderequityworth14989crandtotalassetsworth14989cr,thebalancesheetofTorrentPharmaceuticalsis:
Balancedℹ
.
Cashflow
TorrentPharmaceuticalshas
Poorℹ
cashflowbecausethereis

Shortage

of

₹ 261cr

.Itis
Downℹ
by

180.06

%.
47.61% i.e. ₹ 2585cr earned in operatingℹ
9.94% i.e. ₹ 540cr spent in investingℹ
42.3% i.e. ₹ 2297cr spent in financingℹ
0.15% i.e. ₹ 8cr spent in otherℹ
TorrentPharmaceuticalshas
Excellentℹ
cashflowbecausethereis

Surplus

of

₹ 326cr

.Itis
Upℹ
by

196.36

%.
52.51% i.e. ₹ 3266cr earned in operatingℹ
2.68% i.e. ₹ 167cr spent in investingℹ
44.68% i.e. ₹ 2779cr spent in financingℹ
0.13% i.e. ₹ 8cr earned in otherℹ
Income
TheincomeofTorrentPharmaceuticalsis

₹ 3275cr

and

Profit

is:

₹ 591cr

TorrentPharmaceuticalsProfitisupby:

7.85

%andIncomeisUpby:

4.27

%
TheincomeofTorrentPharmaceuticalsis

₹ 3141cr

and

Profit

is:

₹ 548cr

TorrentPharmaceuticalsProfitisupby:

10.04

%andIncomeisUpby:

6.8

%
TheincomeofTorrentPharmaceuticalsis

₹ 2941cr

and

Profit

is:

₹ 498cr

TorrentPharmaceuticalsProfitisdownby:

0.99

%andIncomeisUpby:

3.48

%
By using this site you agree to the use of cookies to deliver a better site experience.